Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Change in Cash (2016 - 2025)

Amicus Therapeutics filings provide 16 years of Change in Cash readings, the most recent being $23.5 million for Q4 2025.

  • On a quarterly basis, Change in Cash rose 216.69% to $23.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $600000.0, a 101.8% increase, with the full-year FY2025 number at $600000.0, up 101.8% from a year prior.
  • Change in Cash hit $23.5 million in Q4 2025 for Amicus Therapeutics, down from $31.8 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $209.3 million in Q3 2021 to a low of -$139.6 million in Q4 2021.
  • Median Change in Cash over the past 5 years was $800500.0 (2022), compared with a mean of $2.6 million.
  • Biggest five-year swings in Change in Cash: skyrocketed 2321.49% in 2023 and later crashed 5098.4% in 2025.
  • Amicus Therapeutics' Change in Cash stood at -$139.6 million in 2021, then rose by 8.02% to -$128.4 million in 2022, then surged by 87.39% to -$16.2 million in 2023, then decreased by 24.14% to -$20.1 million in 2024, then soared by 216.69% to $23.5 million in 2025.
  • The last three reported values for Change in Cash were $23.5 million (Q4 2025), $31.8 million (Q3 2025), and -$22.7 million (Q2 2025) per Business Quant data.